Because words like “recommendation” have much different meaning from layman usage.
A recommendation has to be made based on milestones. Activ-5 isn’t done, so NIH can’t make a recommendation. They did make a note of Lenzilumab’s effectiveness, but until that trial concludes, there’s no recommendation.
Now we can blame big pharma or politics all day about why it’s not done, but it’s little more than sophistry without hard evidence.